【October Promotion】G-NiiB M3CRC 2 Person Save More Offer!

Colorectal cancer is the second leading cause of cancer in Hong Kong, if you want to protect the health of yourself and your family, you should have regular colorectal cancer screening, G-NiiB E-Shop is conducting G-NiiB M3CRC non-invasive Colorectal Cancer Risk Prediction Test promotion, only $6,580 for 2 person, save up to $1,180, pay with Atome and enjoy 3 monthly payments with 0% interest.

Services include:

1. G-NiiB M3CRC test kit

2. Courier pick-up of G-NiiB M3CRC samples

3. Testing costs

4. Interpretation of the report by the doctor of "Trinity Medical Centre" (Clinic Location: Central / Tsim Sha Tsui).

Promotion period: 26 October to 11 November 2022

Atome Usage Process : http://bit.ly/3z8njPy

What’s G-NiiB M3CRC non-invasive Colorectal Cancer Risk Prediction Test?

G-NiiB M3CRC colorectal cancer risk prediction test that detects non-advanced adenoma and adenoma recurrence, Sensitivity in detecting adenomas and early detection of Colorectal Cancer. Dietary recommendations included

How does M3CRC predict risk of having colorectal cancer, adenoma and adenoma recurrence?

M3CRC measures the levels of m3 (discovered by the Chinese University of Hong Kong) and the other 3 microbial markers plus hemoglobin in the stool. Using our propriety algorithm, we generate 3 risk indices corresponding to colorectal adenoma, colorectal cancer and colorectal adenoma recurrence. Higher risk indices reflect higher risks of having colorectal adenoma, colorectal cancer and colorectal adenoma recurrence.

How is it different from other colorectal cancer screenings?

M3CRC is a world’s only non-invasive colorectal cancer risk prediction test that defects non-advanced adenoma , the sensitivity of CRC is 94% comparable to colonoscopy10 and the specificity is 85%, sensitivity superior to currently available non-invasive test in detecting adenomas. (especially small polyps)1

Am I suitable for G-NiiB M3CRC non-invasive Colorectal Cancer Risk Prediction Test?

Anyone can take the test to stay informed about his or her colorectal cancer-related gut microbial health. The American Cancer Society (ACS) recommends that adults aged 45 years or above with an average risk of colorectal cancer undergo regular screening. In certain high-risk individuals, including those with a family history of colorectal cancer, any inherited mutations, or other known risk factors, screening is recommended to begin at an earlier age. For more information, please consult your doctor.

Can I take the test when I am sick or suffer from long-term health conditions?

Yes, anyone can take our test. Our method of examining your gut bacteria is non-invasive and the initial test can be completed at your home. If you have a medical condition, please consult with a medical professional before making any changes to your diet or lifestyle.

1. TF Imperiale, DF Ransohoff, SH Itzkowitz, TR Levin, P Lavin, GP Lidgard, DA Ahlquist, and BM Berger. Multitarget Stool DN，A Testing for Colorectal-Cancer Screening. The New England Journal of Medicine, 2014.

2. US patent Assessing Risk for Colorectal Adenoma Recurrence by Noninvasive Means (1st Provisional Application No. 63/116104, Filing date: 19 Nov 2020); US patent Assessing Risk for Colorectal Adenoma Recurrence by Noninvasive Means (2nd Provisional Application No. 63/196582, Filing date: 3 Jun 2021)